142 related articles for article (PubMed ID: 10882779)
1. Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors.
Nishimura Y; Ito T; Hoe K; Saavedra JM
Brain Res; 2000 Jul; 871(1):29-38. PubMed ID: 10882779
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
Nishimura Y; Ito T; Saavedra JM
Stroke; 2000 Oct; 31(10):2478-86. PubMed ID: 11022082
[TBL] [Abstract][Full Text] [Related]
3. Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress.
Armando I; Carranza A; Nishimura Y; Hoe KL; Barontini M; Terrón JA; Falcón-Neri A; Ito T; Juorio AV; Saavedra JM
Endocrinology; 2001 Sep; 142(9):3880-9. PubMed ID: 11517166
[TBL] [Abstract][Full Text] [Related]
4. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats.
Gohlke P; Kox T; Jürgensen T; von Kügelgen S; Rascher W; Unger T; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):477-83. PubMed ID: 12070762
[TBL] [Abstract][Full Text] [Related]
5. Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice.
Armando I; Terrón JA; Falcón-Neri A; Takeshi I; Häuser W; Inagami T; Saavedra JM
Neuroendocrinology; 2002 Sep; 76(3):137-47. PubMed ID: 12218346
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.
Nishimura Y; Xu T; Jöhren O; Häuser W; Saavedra JM
Basic Res Cardiol; 1998; 93 Suppl 2():63-8. PubMed ID: 9833166
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
Cervenka L; Wang CT; Navar LG
Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of chronic inhibition of calcium channel and angiotensin II type 1-receptor on aldosterone synthesis in spontaneously hypertensive rats.
Otsuka F; Ogura T; Kataoka H; Kishida M; Takahashi M; Mimura Y; Yamauchi T; Makino H
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):125-36. PubMed ID: 11086231
[TBL] [Abstract][Full Text] [Related]
9. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
Tazawa S; Nakane T; Chiba S
J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.
Seltzer A; Bregonzio C; Armando I; Baiardi G; Saavedra JM
Brain Res; 2004 Nov; 1028(1):9-18. PubMed ID: 15518636
[TBL] [Abstract][Full Text] [Related]
12. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats.
Barber MN; Sampey DB; Widdop RE
Hypertension; 1999 Nov; 34(5):1112-6. PubMed ID: 10567191
[TBL] [Abstract][Full Text] [Related]
13. A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.
Macova M; Pavel J; Saavedra JM
Brain Res; 2009 Jan; 1250():130-40. PubMed ID: 19038235
[TBL] [Abstract][Full Text] [Related]
14. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.
Brännström K; Morsing P; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S213-9. PubMed ID: 9892166
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the angiotensin II Type 1 receptor by TCV-116: quantitation by in vitro autoradiography.
Song K; Kanehara H; Takai S; Shiota N; Wada T; Inada Y; Miyazaki M
Jpn J Pharmacol; 1999 Feb; 79(2):131-9. PubMed ID: 10202848
[TBL] [Abstract][Full Text] [Related]
16. A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding.
Saavedra JM; Armando I; Bregonzio C; Juorio A; Macova M; Pavel J; Sanchez-Lemus E
Neuropsychopharmacology; 2006 Jun; 31(6):1123-34. PubMed ID: 16205776
[TBL] [Abstract][Full Text] [Related]
17. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats.
Bregonzio C; Seltzer A; Armando I; Pavel J; Saavedra JM
Stress; 2008 Nov; 11(6):457-66. PubMed ID: 18609298
[TBL] [Abstract][Full Text] [Related]
19. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
Ito T; Yamakawa H; Bregonzio C; Terrón JA; Falcón-Neri A; Saavedra JM
Stroke; 2002 Sep; 33(9):2297-303. PubMed ID: 12215602
[TBL] [Abstract][Full Text] [Related]
20. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
